BCL
TLSIW icon

Bracebridge Capital LLC’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Bracebridge Capital LLC’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-92,880
Closed -$151K – 43
2024
Q2 		$151K Hold
92,880
– – 0.03% 16
2024
Q1 		$92.9K Sell
92,880
-5,977
-6% -$5.97K 0.01% 19
2023
Q4 		$118K Hold
98,857
– – 0.03% 15
2023
Q3 		$37.6K Hold
98,857
– – 0.01% 20
2023
Q2 		$4.14K Hold
98,857
– – ﹤0.01% 46
2023
Q1 		$6.07K Hold
98,857
– – ﹤0.01% 60
2022
Q4 		$7.41K Hold
98,857
– – ﹤0.01% 78
2022
Q3 		$6K Hold
98,857
– – ﹤0.01% 101
2022
Q2 		$8K Hold
98,857
– – ﹤0.01% 102
2022
Q1 		$25K Buy
+98,857
New +$42.5K ﹤0.01% 102

Other funds holding TLSIW

VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bracebridge Capital LLC's TLSIW Position: Q3 2024 in Review

Bracebridge Capital LLC sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2024, closing a stake of 92,880 shares — an estimated $151K sold.

Bracebridge Capital LLC first reported a position in TLSIW in Q1 2022 and held it in 10 quarters. The position peaked at $151K in Q2 2024. 8 funds tracked by Wall St. Rank hold TLSIW as of Q3 2024.

  • Bracebridge Capital LLC reported no remaining TriSalus Life Sciences Warrant position as of Q3 2024 after selling out during the quarter.
  • Bracebridge Capital LLC sold 92,880 TriSalus Life Sciences Warrant shares in Q3 2024, an estimated $151K.
  • Bracebridge Capital LLC first reported a position in TriSalus Life Sciences Warrant in Q1 2022 and held it in 10 quarters.
  • Bracebridge Capital LLC's TriSalus Life Sciences Warrant position peaked at $151K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2024.

Based on Bracebridge Capital LLC's 13F filing for Q3 2024, filed 14 Nov 2024.